Staphylococcus aureus induces eosinophil cell death mediated by α-Hemolysin

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Prince, Lynne R ^a   Graham, Kirstie J ^a   Connolly, John ^a   Anwar, Sadia ^a   Ridley, Robert ^a   Sabroe, Ian ^a   Foster, Simon J ^a   Whyte, Moira K B ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; AGR PROTEIN, STAPHYLOCOCCUS AUREUS; BACTERIAL PROTEIN; HEMOLYSIN; TRANSACTIVATOR PROTEIN;

AGR GENE; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CELL DEATH; CELL LOSS; CONTROLLED STUDY; EOSINOPHIL; GRANULOCYTE; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; REGULATOR GENE; STAPHYLOCOCCUS AUREUS; CELL CULTURE; CELL GRANULE; DRUG ANTAGONISM; FLOW CYTOMETRY; METABOLISM; PATHOGENICITY; PATHOLOGY; STAPHYLOCOCCUS INFECTION;

STAPHYLOCOCCUS AUREUS;

APOPTOSIS; BACTERIAL PROTEINS; CELLS, CULTURED; CYTOPLASMIC GRANULES; EOSINOPHILS; FLOW CYTOMETRY; HEMOLYSIN PROTEINS; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANS-ACTIVATORS;

EID: 84857072848     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031506     Document Type: Article

References (59)

1. Czech W, Krutmann J, Schopf E, Kapp A, (1992) Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br J Dermatol 126: 351-355.
2. Kagi MK, Joller-Jemelka H, Wuthrich B, (1992) Correlation of eosinophils, eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis. Dermatology 185: 88-92.
3. Gibson PG, Simpson JL, Hankin R, Powell H, Henry RL, (2003) Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma. Thorax 58: 116-121.
4. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, et al. (1998) Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 28: 233-240.
5. Henderson WR, Chi EY, Klebanoff SJ, (1980) Eosinophil peroxidase-induced mast cell secretion. J Exp Med 152: 265-279.
6. Flavahan NA, Slifman NR, Gleich GJ, Vanhoutte PM, (1988) Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am Rev Respir Dis 138: 685-688.
7. Stern M, Meagher L, Savill J, Haslett C, (1992) Apoptosis in human eosinophils. Programmed cell death in the eosinophil leads to phagocytosis by macrophages and is modulated by IL-5. J Immunol 148: 3543-3549.
8. Usher LR, Lawson RA, Geary I, Taylor CJ, Bingle CD, et al. (2002) Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 168: 1861-1868.
9. Dockrell DH, Whyte MK, (2006) Regulation of phagocyte lifespan in the lung during bacterial infection. J Leukoc Biol 79: 904-908.
10. Labbe K, Saleh M, (2008) Cell death in the host response to infection. Cell Death Differ 15: 1339-1349.
11. Min DY, Lee YA, Ryu JS, Ahn MH, Chung YB, et al. (2004) Caspase-3-mediated apoptosis of human eosinophils by the tissue-invading helminth Paragonimus westermani. Int Arch Allergy Immunol 133: 357-364.
12. Serradell MC, Guasconi L, Cervi L, Chiapello LS, Masih DT, (2007) Excretory-secretory products from Fasciola hepatica induce eosinophil apoptosis by a caspase-dependent mechanism. Vet Immunol Immunopathol 117: 197-208.
13. Shin MH, (2000) Excretory-secretory product of newly excysted metacercariae of Paragonimus westermani directly induces eosinophil apoptosis. Korean J Parasitol 38: 17-23.
14. Torrent M, De la Torre BG, Nogues MV, Andreu D, Boix E, (2009) Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem J.
15. Driss V, Legrand F, Hermann E, Loiseau S, Guerardel Y, et al. (2009) TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. Blood 113: 3235-3244.
16. Yousefi S, Gold JA, Andina N, Lee JJ, Kelly AM, et al. (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat Med 14: 949-953.
17. Leung DY, Harbeck R, Bina P, Reiser RF, Yang E, et al. (1993) Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest 92: 1374-1380.
18. De Benedetto A, Agnihothri R, McGirt LY, Bankova LG, Beck LA, (2009) Atopic dermatitis: a disease caused by innate immune defects? J Invest Dermatol 129: 14-30.
19. Bachert C, Zhang N, Patou J, van Zele T, Gevaert P, (2008) Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol 8: 34-38.
20. Zhang N, Gevaert P, van Zele T, Perez-Novo C, Patou J, et al. (2005) An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology 43: 162-168.
21. Bachert C, Gevaert P, Zhang N, van Zele T, Perez-Novo C, (2007) Role of staphylococcal superantigens in airway disease. Chem Immunol Allergy 93: 214-236.
22. Horsburgh MJ, Aish JL, White IJ, Shaw L, Lithgow JK, et al. (2002) sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol 184: 5457-5467.
23. O'Reilly M, de Azavedo JC, Kennedy S, Foster TJ, (1986) Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins. Microb Pathog 1: 125-138.
24. Novick RP, (1991) Genetic systems in staphylococci. Methods Enzymol 204: 587-636.
25. Cooper EL, Garcia-Lara J, Foster SJ, (2009) YsxC, an essential protein in Staphylococcus aureus crucial for ribosome assembly/stability. BMC Microbiol 9: 266.
26. Schenk S, Laddaga RA, (1992) Improved method for electroporation of Staphylococcus aureus. FEMS Microbiol Lett 73: 133-138.
27. Haslett C, Guthrie LA, Kopaniak MM, Johnston RB Jr, Henson PM, (1985) Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide. Am J Pathol 119: 101-110.
28. Sabroe I, Hartnell A, Jopling LA, Bel S, Ponath PD, et al. (1999) Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J Immunol 162: 2946-2955.
29. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, et al. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol 148: 2207-2216.
30. Walsh GM, Dewson G, Wardlaw AJ, Levi-Schaffer F, Moqbel R, (1998) A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. J Immunol Methods 217: 153-163.
31. Novick RP, (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48: 1429-1449.
32. Wichmann K, Uter W, Weiss J, Breuer K, Heratizadeh A, et al. (2009) Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol 161: 300-305.
33. Breuer K, Wittmann M, Kempe K, Kapp A, Mai U, et al. (2005) Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy 35: 1088-1095.
34. Leyden JJ, Marples RR, Kligman AM, (1974) Staphylococcus aureus in the lesions of atopic dermatitis. Br J Dermatol 90: 525-530.
35. Ring J, Abeck D, Neuber K, (1992) Atopic eczema: role of microorganisms on the skin surface. Allergy 47: 265-269.
36. Guzik TJ, Bzowska M, Kasprowicz A, Czerniawska-Mysik G, Wojcik K, et al. (2005) Persistent skin colonization with Staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy 35: 448-455.
37. Nilsson EJ, Henning CG, Magnusson J, (1992) Topical corticosteroids and Staphylococcus aureus in atopic dermatitis. J Am Acad Dermatol 27: 29-34.
38. Huvenne W, Callebaut I, Plantinga M, Vanoirbeek JA, Krysko O, et al. (2010) Staphylococcus aureus enterotoxin B facilitates allergic sensitization in experimental asthma. Clin Exp Allergy.
39. Arbuthnott JP, (1970) Staphylococcal α-toxin. In: Montie TC, Kadis S, editors. Microbial Toxins New York Academic Press pp. 189-236.
40. Menestrina G, Serra MD, Prevost G, (2001) Mode of action of beta-barrel pore-forming toxins of the staphylococcal alpha-hemolysin family. Toxicon 39: 1661-1672.
41. McElroy MC, Harty HR, Hosford GE, Boylan GM, Pittet JF, et al. (1999) Alpha-toxin damages the air-blood barrier of the lung in a rat model of Staphylococcus aureus-induced pneumonia. Infect Immun 67: 5541-5544.
42. Nilsson IM, Hartford O, Foster T, Tarkowski A, (1999) Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun 67: 1045-1049.
43. Bubeck Wardenburg J, Patel RJ, Schneewind O, (2007) Surface proteins and exotoxins are required for the pathogenesis of Staphylococcus aureus pneumonia. Infect Immun 75: 1040-1044.
44. Kielian T, Cheung A, Hickey WF, (2001) Diminished virulence of an alpha-toxin mutant of Staphylococcus aureus in experimental brain abscesses. Infect Immun 69: 6902-6911.
45. Parker MW, Feil SC, (2005) Pore-forming protein toxins: from structure to function. Prog Biophys Mol Biol 88: 91-142.
46. Bantel H, Sinha B, Domschke W, Peters G, Schulze-Osthoff K, et al. (2001) alpha-Toxin is a mediator of Staphylococcus aureus-induced cell death and activates caspases via the intrinsic death pathway independently of death receptor signaling. J Cell Biol 155: 637-648.
47. Essmann F, Bantel H, Totzke G, Engels IH, Sinha B, et al. (2003) Staphylococcus aureus alpha-toxin-induced cell death: predominant necrosis despite apoptotic caspase activation. Cell Death Differ 10: 1260-1272.
48. Haslinger B, Strangfeld K, Peters G, Schulze-Osthoff K, Sinha B, (2003) Staphylococcus aureus alpha-toxin induces apoptosis in peripheral blood mononuclear cells: role of endogenous tumour necrosis factor-alpha and the mitochondrial death pathway. Cell Microbiol 5: 729-741.
49. Jonas D, Walev I, Berger T, Liebetrau M, Palmer M, et al. (1994) Novel path to apoptosis: small transmembrane pores created by staphylococcal alpha-toxin in T lymphocytes evoke internucleosomal DNA degradation. Infect Immun 62: 1304-1312.
50. Menzies BE, Kourteva I, (2000) Staphylococcus aureus alpha-toxin induces apoptosis in endothelial cells. FEMS Immunol Med Microbiol 29: 39-45.
51. Craven RR, Gao X, Allen IC, Gris D, Bubeck Wardenburg J, et al. (2009) Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells. PLoS One 4: e7446.
52. da Silva MC, Zahm JM, Gras D, Bajolet O, Abely M, et al. (2004) Dynamic interaction between airway epithelial cells and Staphylococcus aureus. Am J Physiol Lung Cell Mol Physiol 287: L543-551.
53. Valeva A, Walev I, Pinkernell M, Walker B, Bayley H, et al. (1997) Transmembrane beta-barrel of staphylococcal alpha-toxin forms in sensitive but not in resistant cells. Proc Natl Acad Sci U S A 94: 11607-11611.
54. Bramley AJ, Patel AH, O'Reilly M, Foster R, Foster TJ, (1989) Roles of alpha-toxin and beta-toxin in virulence of Staphylococcus aureus for the mouse mammary gland. Infect Immun 57: 2489-2494.
55. Patel AH, Nowlan P, Weavers ED, Foster T, (1987) Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 55: 3103-3110.
56. Kennedy AD, Bubeck Wardenburg J, Gardner DJ, Long D, Whitney AR, et al. (2010) Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis 202: 1050-1058.
57. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, et al. (2011) Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 204: 937-941.
58. Hogan SP, Rosenberg HF, Moqbel R, Phipps S, Foster PS, et al. (2008) Eosinophils: biological properties and role in health and disease. Clin Exp Allergy 38: 709-750.
59. Lim KG, Wan HC, Bozza PT, Resnick MB, Wong DT, et al. (1996) Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol 156: 2566-2570.